Patrick John Jermain Sells 2,643 Shares of Plexus Corp. (NASDAQ:PLXS) Stock

Plexus Corp. (NASDAQ:PLXSGet Free Report) CFO Patrick John Jermain sold 2,643 shares of the company’s stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $166.32, for a total value of $439,583.76. Following the completion of the sale, the chief financial officer now owns 21,959 shares of the company’s stock, valued at approximately $3,652,220.88. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Patrick John Jermain also recently made the following trade(s):

  • On Monday, October 28th, Patrick John Jermain sold 5,045 shares of Plexus stock. The shares were sold at an average price of $143.13, for a total transaction of $722,090.85.

Plexus Price Performance

PLXS opened at $165.97 on Friday. The firm has a market capitalization of $4.52 billion, a P/E ratio of 41.39 and a beta of 0.87. The stock has a fifty day moving average of $136.01 and a 200-day moving average of $120.28. The company has a quick ratio of 0.71, a current ratio of 1.51 and a debt-to-equity ratio of 0.07. Plexus Corp. has a 12-month low of $90.18 and a 12-month high of $169.41.

Plexus (NASDAQ:PLXSGet Free Report) last announced its quarterly earnings data on Wednesday, October 23rd. The technology company reported $1.85 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.55 by $0.30. Plexus had a return on equity of 9.51% and a net margin of 2.82%. The firm had revenue of $1.05 billion during the quarter, compared to the consensus estimate of $1.01 billion. During the same period in the prior year, the business earned $1.44 EPS. The business’s revenue for the quarter was up 2.6% on a year-over-year basis. Equities analysts forecast that Plexus Corp. will post 6.2 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Intech Investment Management LLC acquired a new stake in shares of Plexus during the 3rd quarter valued at $755,000. Moran Wealth Management LLC raised its holdings in shares of Plexus by 4.0% during the third quarter. Moran Wealth Management LLC now owns 52,412 shares of the technology company’s stock worth $7,165,000 after acquiring an additional 1,994 shares in the last quarter. Advisors Asset Management Inc. raised its holdings in shares of Plexus by 85.0% during the third quarter. Advisors Asset Management Inc. now owns 664 shares of the technology company’s stock worth $91,000 after acquiring an additional 305 shares in the last quarter. Natixis Advisors LLC boosted its position in Plexus by 13.4% during the third quarter. Natixis Advisors LLC now owns 18,923 shares of the technology company’s stock valued at $2,587,000 after purchasing an additional 2,235 shares during the last quarter. Finally, CIBC Asset Management Inc purchased a new position in Plexus in the third quarter valued at about $253,000. 94.45% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several analysts recently commented on PLXS shares. Needham & Company LLC increased their target price on shares of Plexus from $144.00 to $162.00 and gave the company a “buy” rating in a research note on Friday, October 25th. StockNews.com downgraded Plexus from a “buy” rating to a “hold” rating in a research report on Wednesday. Benchmark lifted their target price on Plexus from $150.00 to $165.00 and gave the stock a “buy” rating in a report on Monday, October 28th. Finally, KeyCorp initiated coverage on Plexus in a research report on Tuesday, October 22nd. They issued a “sector weight” rating for the company. Four equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $133.50.

Read Our Latest Stock Analysis on PLXS

About Plexus

(Get Free Report)

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.

Featured Articles

Insider Buying and Selling by Quarter for Plexus (NASDAQ:PLXS)

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.